Loading...
bioAffinity Technologies, Inc.
BIAF•NASDAQ
Healthcare
Medical - Diagnostics & Research
$0.33
$-0.02(-4.75%)
bioAffinity Technologies, Inc. (BIAF) Financial Performance & Income Statement Overview
Review bioAffinity Technologies, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
269.68%
↑ 269.68%
Operating Income Growth
-12.29%
↓ 12.29%
Net Income Growth
-13.89%
↓ 13.89%
Operating Cash Flow Growth
-20.32%
↓ 20.32%
Operating Margin
-109.38%
↓ 109.38%
Gross Margin
34.41%
↑ 34.41%
Net Profit Margin
-110.55%
↓ 110.55%
ROE
-367.64%
↓ 367.64%
ROIC
-451.97%
↓ 451.97%
bioAffinity Technologies, Inc. (BIAF) Income Statement & Financial Overview
Review bioAffinity Technologies, Inc.'s (BIAF) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.85M | $2.21M | $2.35M | $2.40M |
| Cost of Revenue | $0.00 | $1.56M | $1.44M | $1.41M |
| Gross Profit | $0.00 | $645427.00 | $910228.00 | $989942.00 |
| Gross Profit Ratio | $0.00 | $0.29 | $0.39 | $0.41 |
| R&D Expenses | $367386.00 | $518186.00 | $368202.00 | $453895.00 |
| SG&A Expenses | $2.45M | $2.92M | $2.36M | $2.47M |
| Operating Expenses | $4.48M | $3.59M | $2.88M | $3.08M |
| Total Costs & Expenses | $0.00 | $5.15M | $4.32M | $4.49M |
| Interest Income | $542.00 | $4069.00 | $2228.00 | $5186.00 |
| Interest Expense | -$15485.00 | $25045.00 | $21631.00 | $22249.00 |
| Depreciation & Amortization | $154588.00 | $153632.00 | $151298.00 | $151070.00 |
| EBITDA | -$2.53M | -$2.79M | -$1.82M | -$1.93M |
| EBITDA Ratio | -$1.36 | -$1.26 | -$0.78 | -$0.81 |
| Operating Income | -$2.63M | -$2.95M | -$1.97M | -$2.09M |
| Operating Income Ratio | -$1.42 | -$1.33 | -$0.84 | -$0.87 |
| Other Income/Expenses (Net) | -$24583.00 | -$20344.00 | -$24417.00 | -$17062.00 |
| Income Before Tax | -$2.65M | -$2.97M | -$2.00M | -$2.10M |
| Income Before Tax Ratio | -$1.43 | -$1.34 | -$0.85 | -$0.88 |
| Income Tax Expense | -$8695.00 | -$23300.00 | $2559.00 | $5419.00 |
| Net Income | -$2.66M | -$2.97M | -$2.001M | -$2.11M |
| Net Income Ratio | -$1.44 | -$1.34 | -$0.85 | -$0.88 |
| EPS | -$0.16 | -$0.16 | -$0.16 | -$0.19 |
| Diluted EPS | -$0.16 | -$0.16 | -$0.16 | -$0.19 |
| Weighted Avg Shares Outstanding | $16.26M | $12.39M | $12.39M | $11.39M |
| Weighted Avg Shares Outstanding (Diluted) | $16.26M | $12.39M | $12.39M | $11.39M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan